Daito Pharmaceutical Co., Ltd.

Greenhouse gas emissions & sustainability report data

๐Ÿ“Š Latest report period: 2024๐Ÿ—‚๏ธ Report periods on file: 2024, 2023-06 to 2024-05

Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

๐Ÿ“ˆ Emissions by Report Period

Report periodHeadline emissions figure reported
2023-06 to 2024-0528.4K t-CO2e (้€ฃ็ต)

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

๐ŸŒฑ ESG Focus Areas

Human Rights

โš ๏ธ Challenges & Risks +

  • Potential adverse human rights impacts throughout the value chain.

๐Ÿ“‹ Report Information

Reporting Period: 2024
Frameworks: UN Guiding Principles on Business and Human Rights, International Bill of Human Rights, ILO Declaration on Fundamental Principles and Rights at Work, Ethical Principles for Medical Research Involving Human Subjects (Declaration of Helsinki)

More companies (D)

See all companies starting with D โ†’

Data source: figures were extracted with AI from the company's publicly available sustainability or annual report and have not been independently verified. Always check the original report before relying on a number.

Disclaimer | Report an error or request removal